These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 22020633)

  • 1. Abnormal accumulation of autophagic vesicles correlates with axonal and synaptic pathology in young Alzheimer's mice hippocampus.
    Sanchez-Varo R; Trujillo-Estrada L; Sanchez-Mejias E; Torres M; Baglietto-Vargas D; Moreno-Gonzalez I; De Castro V; Jimenez S; Ruano D; Vizuete M; Davila JC; Garcia-Verdugo JM; Jimenez AJ; Vitorica J; Gutierrez A
    Acta Neuropathol; 2012 Jan; 123(1):53-70. PubMed ID: 22020633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer's disease.
    Sadleir KR; Kandalepas PC; Buggia-Prévot V; Nicholson DA; Thinakaran G; Vassar R
    Acta Neuropathol; 2016 Aug; 132(2):235-256. PubMed ID: 26993139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of Abeta-plaques on cortical cholinergic and non-cholinergic presynaptic boutons in alzheimer's disease-like transgenic mice.
    Hu L; Wong TP; Côté SL; Bell KF; Cuello AC
    Neuroscience; 2003; 121(2):421-32. PubMed ID: 14522000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of cytoskeletal abnormalities in mice transgenic for wild-type human tau and familial Alzheimer's disease mutants of APP and presenilin-1.
    Boutajangout A; Authelet M; Blanchard V; Touchet N; Tremp G; Pradier L; Brion JP
    Neurobiol Dis; 2004 Feb; 15(1):47-60. PubMed ID: 14751770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective lysosomal proteolysis and axonal transport are early pathogenic events that worsen with age leading to increased APP metabolism and synaptic Abeta in transgenic APP/PS1 hippocampus.
    Torres M; Jimenez S; Sanchez-Varo R; Navarro V; Trujillo-Estrada L; Sanchez-Mejias E; Carmona I; Davila JC; Vizuete M; Gutierrez A; Vitorica J
    Mol Neurodegener; 2012 Nov; 7():59. PubMed ID: 23173743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plaque-Associated Oligomeric Amyloid-Beta Drives Early Synaptotoxicity in APP/PS1 Mice Hippocampus: Ultrastructural Pathology Analysis.
    Sanchez-Varo R; Sanchez-Mejias E; Fernandez-Valenzuela JJ; De Castro V; Mejias-Ortega M; Gomez-Arboledas A; Jimenez S; Sanchez-Mico MV; Trujillo-Estrada L; Moreno-Gonzalez I; Baglietto-Vargas D; Vizuete M; Davila JC; Vitorica J; Gutierrez A
    Front Neurosci; 2021; 15():752594. PubMed ID: 34803589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early neuronal loss and axonal/presynaptic damage is associated with accelerated amyloid-β accumulation in AβPP/PS1 Alzheimer's disease mice subiculum.
    Trujillo-Estrada L; Dávila JC; Sánchez-Mejias E; Sánchez-Varo R; Gomez-Arboledas A; Vizuete M; Vitorica J; Gutiérrez A
    J Alzheimers Dis; 2014; 42(2):521-41. PubMed ID: 24927710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Farnesyltransferase inhibitor LNK-754 attenuates axonal dystrophy and reduces amyloid pathology in mice.
    Cuddy LK; Alia AO; Salvo MA; Chandra S; Grammatopoulos TN; Justman CJ; Lansbury PT; Mazzulli JR; Vassar R
    Mol Neurodegener; 2022 Aug; 17(1):54. PubMed ID: 35987691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease.
    Ye X; Feng T; Tammineni P; Chang Q; Jeong YY; Margolis DJ; Cai H; Kusnecov A; Cai Q
    J Neurosci; 2017 Mar; 37(10):2639-2655. PubMed ID: 28159908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PDAPP; YFP double transgenic mice: a tool to study amyloid-beta associated changes in axonal, dendritic, and synaptic structures.
    Brendza RP; O'Brien C; Simmons K; McKeel DW; Bales KR; Paul SM; Olney JW; Sanes JR; Holtzman DM
    J Comp Neurol; 2003 Feb; 456(4):375-83. PubMed ID: 12532409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BACE1 elevation is involved in amyloid plaque development in the triple transgenic model of Alzheimer's disease: differential Aβ antibody labeling of early-onset axon terminal pathology.
    Cai Y; Zhang XM; Macklin LN; Cai H; Luo XG; Oddo S; Laferla FM; Struble RG; Rose GM; Patrylo PR; Yan XX
    Neurotox Res; 2012 Feb; 21(2):160-74. PubMed ID: 21725719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Most dystrophic neurites in the common 5xFAD Alzheimer mouse model originate from axon terminals.
    Mabrouk R; Miettinen PO; Tanila H
    Neurobiol Dis; 2023 Jun; 182():106150. PubMed ID: 37172911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exclusive association and simultaneous appearance of congophilic plaques and AT8-positive dystrophic neurites in Tg2576 mice suggest a mechanism of senile plaque formation and progression of neuritic dystrophy in Alzheimer's disease.
    Noda-Saita K; Terai K; Iwai A; Tsukamoto M; Shitaka Y; Kawabata S; Okada M; Yamaguchi T
    Acta Neuropathol; 2004 Nov; 108(5):435-42. PubMed ID: 15372280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrastructural studies in APP/PS1 mice expressing human ApoE isoforms: implications for Alzheimer's disease.
    Dikranian K; Kim J; Stewart FR; Levy MA; Holtzman DM
    Int J Clin Exp Pathol; 2012; 5(6):482-95. PubMed ID: 22949930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced autophagic retrograde axonal transport by dynein intermediate chain upregulation improves Aβ clearance and cognitive function in APP/PS1 double transgenic mice.
    Zhou F; Xiong X; Li S; Liang J; Zhang X; Tian M; Li X; Gao M; Tang L; Li Y
    Aging (Albany NY); 2020 Jun; 12(12):12142-12159. PubMed ID: 32584265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse amyloid deposition, but not plaque number, is reduced in amyloid precursor protein/presenilin 1 double-transgenic mice by pathway lesions.
    van Groen T; Liu L; Ikonen S; Kadish I
    Neuroscience; 2003; 119(4):1185-97. PubMed ID: 12831872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42).
    Rockenstein E; Mallory M; Mante M; Sisk A; Masliaha E
    J Neurosci Res; 2001 Nov; 66(4):573-82. PubMed ID: 11746377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phagocytic clearance of presynaptic dystrophies by reactive astrocytes in Alzheimer's disease.
    Gomez-Arboledas A; Davila JC; Sanchez-Mejias E; Navarro V; Nuñez-Diaz C; Sanchez-Varo R; Sanchez-Mico MV; Trujillo-Estrada L; Fernandez-Valenzuela JJ; Vizuete M; Comella JX; Galea E; Vitorica J; Gutierrez A
    Glia; 2018 Mar; 66(3):637-653. PubMed ID: 29178139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High plasticity of axonal pathology in Alzheimer's disease mouse models.
    Blazquez-Llorca L; Valero-Freitag S; Rodrigues EF; Merchán-Pérez Á; Rodríguez JR; Dorostkar MM; DeFelipe J; Herms J
    Acta Neuropathol Commun; 2017 Feb; 5(1):14. PubMed ID: 28173876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
    Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL
    Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.